-
-
-
-
-
-
-
Fortress Biotech (FBIO) Closes Sale of Checkpoint Therapeutics
-
-
-
-
-
-
-
Fortress Biotech (FBIO) and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101
-
-
-
-
-
-
-
Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027
-
-
-
1,160,659 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

